Søgning på udtrykket 'evusheld' giver 4 resultater


Nyt fra tidsskrifterne [2] Aktuelle smitsomme sygdomme [2]

Nyt fra tidsskrifterne [2]

Journal of the American Medical Association
25.01.2022
This Medical Letter review summarizes the use of tixagevimab and cilgavimab (Evusheld), investigational long-acting monoclonal antibodies to be administered concomitantly by intramuscular injection for preexposure prophylaxis of COVID-19 in persons aged 12 years or older.
Journal of the American Medical Association
25.01.2022
This Medical Letter review summarizes the use of tixagevimab and cilgavimab (Evusheld), investigational long-acting monoclonal antibodies to be administered concomitantly by intramuscular injection for preexposure prophylaxis of COVID-19 in persons aged 12 years or older.

Aktuelle smitsomme sygdomme [2]

Medscape Infectious Diseases
9.05.2022
WebMD's Chief Medical Officer, John Whyte, MD, discusses the new FDA-authorized preventative drug for COVID-19 called Evusheld. .
Medscape Infectious Diseases
9.05.2022
WebMD's Chief Medical Officer, John Whyte, MD, discusses the new FDA-authorized preventative drug for COVID-19 called Evusheld. .

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,602 s

Cookies og privatliv